These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 400689

  • 1. Recovery of CFU-C after freezing of normal and leukemic human bone marrow.
    Robinson WA, Drebing C, Mahmood T, Entringer M, Redecker S.
    Exp Hematol; 1979; 7 Suppl 5():27-37. PubMed ID: 400689
    [Abstract] [Full Text] [Related]

  • 2. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
    Roodman GD, LeMaistre CF, Clark GM, Page CP, Newcomb TF, Knight WA.
    Bone Marrow Transplant; 1987 Aug; 2(2):165-73. PubMed ID: 3332164
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR, Olson AC, Berdel WE, Okamoto S, Glasser L.
    Prog Clin Biol Res; 1990 Aug; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abnormal regulation of granulopoiesis by bone marrow fibroblasts in leukemia.
    Shimizu M, Nagao T, Arimori S.
    Tokai J Exp Clin Med; 1987 May; 12(2):67-72. PubMed ID: 3482486
    [Abstract] [Full Text] [Related]

  • 7. Isolation, cryopreservation, and autotransplantation of human stem cells.
    Wells JR, Ho WG, Graze P, Sullivan A, Gale RP, Cline MJ.
    Exp Hematol; 1979 May; 7 Suppl 5():12-20. PubMed ID: 45456
    [Abstract] [Full Text] [Related]

  • 8. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF, Griffin JD, Kessler SW, Cutting MA, Knight RD, Blattler WA, Lambert JM, Wright DG.
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [Abstract] [Full Text] [Related]

  • 9. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 10. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 11. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM, Yeager AM.
    Exp Hematol; 1991 Mar 15; 19(3):179-84. PubMed ID: 1704843
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Growth factor stimulation of cryopreserved CD34+ bone marrow cells intended for transplant: an in vitro study to determine optimal timing of exposure to early acting cytokines.
    Ratajczak MZ, Ratajczak J, Kregenow DA, Gewirtz AM.
    Stem Cells; 1994 Nov 15; 12(6):599-603. PubMed ID: 7533578
    [Abstract] [Full Text] [Related]

  • 17. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
    Murphy PB, Richman CM.
    Exp Hematol; 1989 Dec 15; 17(11):1105-9. PubMed ID: 2583254
    [Abstract] [Full Text] [Related]

  • 18. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohamed R.
    Exp Hematol; 1995 Dec 15; 23(14):1661-6. PubMed ID: 8542962
    [Abstract] [Full Text] [Related]

  • 19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 20. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM, Gulati SC.
    Exp Hematol; 1990 Oct 15; 18(9):1008-12. PubMed ID: 2397748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.